HomeProgram ▶ Conference Faculty and Planners Disclosures
Conference Faculty and Planners Disclosures

In accordance with the ACCME Standards for Commercial Support, and those of the ATS Policy on Management of Conflict of Interest in Official ATS Documents, Projects and Conferences, ATS Policy Governing Relationships Between the Tobacco Industry, ATS Members, and Non-Members Who Participate in ATS Activities, and ATS Policy on Professionalism and Ethical Conduct chairs, moderators, presenters and official planners of the International Conference are required to disclose to ATS any potential conflicts of interest (COI) held by them or their spouse/life partner relevant to their presentation(s) or conference role, including all professional or other financial involvement with tobacco or e-cigarette entities, all relevant financial relationships with commercial interests, and all other relationships that could be perceived as influencing their participation. Conference presenters are also asked to disclose if there will be any discussion in the presentation of “off-label” (unapproved) use of substances/products not approved in the United States for the use under discussion (as per the U.S. Food and Drug Administration Guidance for Industry: Industry-Supported Scientific and Educational Activities).

For the 2019 International Conference, this disclosure information for all individuals in control of content was requested and received by ATS in advance of the Conference, reviewed by appropriate ATS reviewers, and session chairs and others in positions of authority were instructed to manage (resolve) identified faculty conflicts according to procedures overseen by the ATS Ethics and Conflict of Interest Committee.

Faculty Disclosures

To access the disclosures made by the faculty of the 2019 International Conference, please go to

Planners Disclosures

The following members of the Education Committee have disclosed no financial relationships with commercial interests:

Debra M. Boyer, MD, Chair
Tisha S. Wang, MD, Vice Chair
Shozab Ahmed, MBBS
William G. Carlos, MD
Josalyn L. Cho, MD
Alison S. Clay, MD
Jessica A. Cooksey, MD
Basak Coruh, MD
Daniel R. Crouch, MD, MS
Charles Dela Cruz, MD, PhD
Fei Jamie Dy, MD
Garth Garrison, MD
Jeffrey R. Goldstein
Jane E. Gross, MD, PhD
Robin L. Gross, MD
Margaret M. Hayes, MD
Amjad Horani, MD
Shazia M. Jamil, MD
Jon M. Keller, MD
Hrishikesh S. Kulkarni, MD
Melissa Lipford, MD
Jakob I. McSparron, MD
Paul E. Moore, MD
Viswam S. Nair, MSCR, MD
Scott S. Oh, DO
Susan Pasnick, MD
Hetal J. Patel, MD
Samaan Rafeq, MD
Jordan S. Rettig, MD
Leopoldo N. Segal, MD
Mary E. Strek, MD, ATSF

The following members of the Education Committee have disclosed the following financial relationships with commercial interests:

Caralee E. Caplan-Shaw, MD: AstraZeneca, Novartis (Research Support); Cohero Health (Consultant; Ownership or investment interests); Cook Incorporated (Food & Beverage Only; CME Speaker); Intuitive Surgical (Spouse-Speaker); Veran Medical Technologies (Spouse-Food & Beverage Only)
Colleen L. Channick, MD: Actelion, Arena Pharmaceuticals, Bayer, Medtronic, Intuitive Surgical (Consultant)
Tristan J. Huie, MD: Boehringer Ingelheim (Consultant, Research Support); Genentech (Consultant); Promedior (Research Support)
Robert L. Owens, MD: ResMed (Other transfers of value)
Mark D. Siegel, MD: McGraw Hill (Co-Editor-no financial compensation); UpToDate (Royalties, Author)

The following members of the International Conference Committee have disclosed no financial relationships with commercial interests:

Jess Mandel, MD, Chair
Alison K. Bauer, PhD
Sebastien Bonnet, PhD, MSc
Vinicio De Jesus Perez, MD
Charles Dela Cruz, MD, PhD
Michelle Eakin, PhD
Eddy Fan, MD, PhD
Jill L. Guttormson, PhD, MS, RN
Ilona Jaspers, PhD
Meeta Prasad Kerlin, MD
Leila Kheirandish-Gozal, MD, MS
Sharon A. McGrath-Morrow, MD
Sangeeta Mehta, MD
Patrick Nana-Sinkam, MD
Enid R. Neptune, MD
Y.S. Prakash, MD, PhD
Angela Rogers, MPH, MD
Chun Seow, PhD

The following members of the International Conference Committee have disclosed the following financial relationships with commercial interests:

Eric S. White, MD, MS: Chair Appointee: Boehringer-Ingelheim (Advisory Committee)
Brian W. Carlin, MD: AstraZeneca (Advisory Committee); GlaxoSmithKline (Consultant); Monaghan Medical Corporation (Consultant, Speaker); Sunovion (Speaker)
Harold R. Collard, MD: Genentech (Advisory Committee); Bayer, Boehringer Ingelheim, Global Blood Therapeutics, Parexel, Prometic, Toray, Unity (Consultant)
Sharon D.M. Dell, MD: Novartis (Advisory Committee, Speaker), Trudell, Vertex (Advisory Committee)
Bradley A. Edwards, PhD: Oventus Medical (Research Support)

Maryl Kreider, MD, MSCE: Gilead, MedImmune, Sanofi (Research Support)
Benjamin D. Medoff, MD: Regeneron (Advisory Committee)
Anne Marie Russell, MScN: Roche (Advisory Committee, Consultant, Research Support, Speaker)
Michael Steiner, MBBS, MD: Boehringer Ingelheim (Consultant, Other Transfers of Value, Speaker); GlaxoSmithKline (Advisory Committee); Nutricia (Consultant)
Rachel Thomson, MBBS: Insmed (Advisory Committee, Consultant); Savara (Consultant)

Anil Vachani, MD: Broncus Medical, Integrated Diagnostics, MagArray (Research Support); Onocyte (Advisory Committee, Research Support); Veracyte (Consultant); Aaronson Rapaport Feinstein & Deutsch, LLP, Bekman, Marder & Adkins, LLC, McAloon & Friedman, PC, McGuire Woods, LLC, Obermeyer Rebman Maxwell & Hippel LLP, United States Attorney’s Office, Wilcox & Savage, PC (Expert Testimony)
Lisa R. Young, MD: Boehringer-Ingelheim (Advisory Committee)